Porosity and mechanically optimized PLGA based in situ hardening systems.

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Orthopedic Engineering

Background:

• Development of effective bone grafting materials is crucial for orthopedic applications.
• Poly(lactic-co-glycolic acid) (PLGA) based systems offer tunable properties for tissue engineering.

Purpose of the Study:

• To develop and characterize in situ-hardening, porous PLGA-based systems for bone grafting.
• To investigate the influence of solvents, pore-forming agents, and fillers on scaffold properties.
• To assess the cell compatibility and potential for in vivo application of the developed scaffolds.

Main Methods:

• Investigated precipitation behavior of PLGA formulations with solvents (DMSO, PEG 400, NMP).
• Incorporated sodium carboxymethylcellulose (NaCMC) as a pore-forming agent and alpha-tricalcium phosphate (α-TCP) as a mechanical enhancer.
• Evaluated scaffold morphology upon water contact and cell compatibility using live/dead assays.

Main Results:

• Successfully developed in situ-hardening scaffolds (IsHS) with tunable porosity and enhanced mechanical properties using PLGA, NaCMC, and α-TCP.
• Demonstrated cell compatibility of hardened scaffolds and successful incorporation of cells via precultivation on α-TCP.
• Identified solvent toxicity as a limitation for maintaining cell viability in vitro, but predicted good cell penetration and proliferation in vivo.

Conclusions:

• The in situ hardening system is a promising candidate for manufacturing custom-shaped, porous bone scaffolds ex vivo.
• The developed scaffolds exhibit mechanical stability, elasticity, and porosity suitable for non-weight-bearing orthopedic indications.
• Further in vivo studies are warranted to confirm the therapeutic potential of these PLGA-based composite scaffolds.